SCHEMBL6053227

SCHEMBL6053227

CCCCCCCCCCC(O)C(C)(C)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.45
SPHK1 Q9NYA1 2/20 0.45
FFAR1 O14842 2/20 0.45
LMNA P02545 2/20 0.44
FDPS P14324 3/20 0.44
CYP2D6 P10635 2/20 0.42
GMNN O75496 1/20 0.42
POLB P06746 1/20 0.42
THPO P40225 1/20 0.42
MTOR P42345 1/20 0.42
BLM P54132 1/20 0.42
KDM4E B2RXH2 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
CETP P11597 1/20 0.42
HTT P42858 1/20 0.42
UBE2N P61088 1/20 0.42
CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16074866 1.00 GPR84 (0.45) GPR84SPHK1FFAR1LMNAFDPS
SCHEMBL16074883 1.00 GPR84 (0.45) GPR84SPHK1FFAR1LMNAFDPS
SCHEMBL16074773 1.00 GPR84 (0.45) GPR84SPHK1FFAR1LMNAFDPS
SCHEMBL16074853 1.00 GPR84 (0.45) GPR84SPHK1FFAR1LMNAFDPS
SCHEMBL16074930 1.00 GPR84 (0.45) GPR84SPHK1FFAR1LMNAFDPS
SCHEMBL5898206 1.00 GPR84 (0.45) GPR84SPHK1FFAR1LMNAFDPS
SCHEMBL16074907 1.00 GPR84 (0.45) GPR84SPHK1FFAR1LMNAFDPS
SCHEMBL16074728 1.00 GPR84 (0.45) GPR84SPHK1FFAR1LMNAFDPS
SCHEMBL16074898 1.00 GPR84 (0.45) GPR84SPHK1FFAR1LMNAFDPS
SCHEMBL16074921 1.00 GPR84 (0.45) GPR84SPHK1FFAR1LMNAFDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3959283-A1 LAMINATION ADHESIVE FOR STERILISATION Bostik SA (FR) 2022-03-02 EP disclosed
WO-2020217023-A1 LAMINATION ADHESIVE FOR STERILISATION BOSTIK SA (FR) 2020-10-29 WO disclosed
US-9188866-B2 Composition for forming titanium-containing resist underlayer film and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-11-17 US disclosed
US-9176382-B2 Composition for forming titanium-containing resist underlayer film and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-11-03 US disclosed
US-9176382-B2 Composition for forming titanium-containing resist underlayer film and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-11-03 US disclosed
US-20140273448-A1 COMPOSITION FOR FORMING TITANIUM-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-09-18 US disclosed
US-20140273448-A1 COMPOSITION FOR FORMING TITANIUM-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-09-18 US disclosed
US-20140273447-A1 COMPOSITION FOR FORMING TITANIUM-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-09-18 US disclosed
US-20140273447-A1 COMPOSITION FOR FORMING TITANIUM-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-09-18 US disclosed
EP-0970952-B1 PROCESSES FOR PREPARING 2-OMEGA-ALKOXYCARBONYLALKANOYL)-4-BUTANOLIDES, OMEGA-HYDROXY-OMEGA-3)-KETO FATTY ESTERS, AND DERIVATIVES THEREOF SODA AROMATIC COMPANY LTD (JP) 2006-08-09 EP disclosed
US-6600070-B2 Chemical intermediates for large cyclic lactone-based perfumes, formed by condensation reaction of gamma-butyrolactone with a dicarboxylate ester SODA AROMATIC CO., LTD. (JP) 2003-07-29 US disclosed
US-6528668-B2 Perfumes TORAY INDUSTRIES, INC. (JP) 2003-03-04 US disclosed
US-6475133-B2 Methods for making 2-(ω-alkoxycarbonylalkanoyl)-4-butanolide, ester of omega-hydroxy-(ω-3)-ketoaliphatic acid, and derivatives thereof SODA AROMATIC CO., LTD. (JP) 2002-11-05 US disclosed
US-20020133028-A1 Methods for making 2-(omega-alkoxycarbonylalkanoyl) -4-butanolide, ester of omega-Hydroxy-(omega-3) -ketoaliphatic acid, and derivatives thereof SODA AROMATIC CO., LTD. 2002-09-19 US disclosed
US-20020068832-A1 Methods for making 2-(omega-alkoxycarbonylalkanoyl) -4-butanolide, ester of omega-hydroxy - ( omega-3 ) -ketoaliphatic acid, and derivatives thereof SODA AROMATIC CO., LTD. 2002-06-06 US disclosed
US-20010051734-A1 Methods for making 2-(omega-alkoxycarbonylalkanoyl) -4-butanolide, ester of omega-hydroxy- (omega-3) - ketoaliphatic acid, and derivatives thereof SODA AROMATIC CO., LTD. 2001-12-13 US disclosed
US-6291688-B1 CONDENSING .GAMMA.-BUTYROLACTONE WITH A DICARBOXYLATE ESTER BY HEATING AND STIRRING TO FORM 2-(.OMEGA.-ALKOXYCARBONYLALKANOYL)-4-BUTANOLIDE AND ITS ALKALI METAL SALT SODA AROMATIC CO., LTD. (JP) 2001-09-18 US disclosed
EP-0970952-A1 PROCESSES FOR PREPARING 2-($g(v)-ALKOXYCARBONYLALKANOYL)-4-BUTANOLIDES, $g(v)-HYDROXY-($g(v)-3)-KETO FATTY ESTERS, AND DERIVATIVES THEREOF SODA AROMATIC COMPANY, LIMITED (JP) 2000-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020133028-A1 Methods for making 2-(omega-alkoxycarbonylalkanoyl) -4-butanolide, ester of omega-Hydroxy-(omega-3) -ketoaliphatic acid, and derivatives thereof SCD, FFAR3, ELOVL3 GPR84 821/4885SPHK1 952/4885FFAR1 30/4885
US-20010051734-A1 Methods for making 2-(omega-alkoxycarbonylalkanoyl) -4-butanolide, ester of omega-hydroxy- (omega-3) - ketoaliphatic acid, and derivatives thereof SCD, ELOVL3, HACD3 GPR84 916/4885SPHK1 846/4885FFAR1 37/4885
US-20020068832-A1 Methods for making 2-(omega-alkoxycarbonylalkanoyl) -4-butanolide, ester of omega-hydroxy - ( omega-3 ) -ketoaliphatic acid, and derivatives thereof SCD, ELOVL3, HACD3 GPR84 916/4885SPHK1 846/4885FFAR1 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.